Le Lézard
Classified in: Health, Science and technology
Subject: RCL

FDA Warns Consumers Not to Use Certain Powdered Infant Formula Produced in Abbott Nutrition's Facility in Sturgis, Michigan


SILVER SPRING, Md., Feb. 17, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it is investigating consumer complaints of Cronobacter sakazakii and Salmonella Newport infections. All of the cases are reported to have consumed powdered infant formula produced from Abbott Nutrition's Sturgis, Michigan facility. As a result of the ongoing investigation, along with the U.S. Centers for Disease Control and Prevention and state and local partners, the FDA is alerting consumers to avoid purchasing or using certain powdered infant formula products produced at this facility. This is an ongoing investigation, and the firm is working with the FDA to initiate a voluntary recall of the potentially affected product. 

The FDA is advising consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:

The FDA is investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA has initiated an onsite inspection at the facility. Findings to date include several positive Cronobacter sakazakii results from environmental samples taken by the FDA and adverse inspectional observations by the FDA investigators. A review of the firm's internal records also indicate environmental contamination with Cronobacter sakazakii and the firm's destruction of product due to the presence of Cronobacter.

"As this is a product used as the sole source of nutrition for many of our nation's newborns and infants, the FDA is deeply concerned about these reports of bacterial infections," said Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response. "We want to reassure the public that we're working diligently with our partners to investigate complaints related to these products, which we recognize include infant formula produced at this facility, while we work to resolve this safety concern as quickly as possible."

Additional Information:

The FDA is continuing to investigate and will provide additional consumer safety information when it becomes available.

Additional Resources:

Media Contact: Veronika Pfaeffle, 301-310-2576
Consumer Inquiries: 888-723-3366

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

U.S. Food and Drug Administration (FDA) logo (PRNewsfoto/FDA)

 

SOURCE U.S. Food and Drug Administration


These press releases may also interest you

at 08:10
Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, announced today the appointment of a new independent director, Neela Patel, Ph.D., to the company's Board of Directors. Dr. Patel is a seasoned...

at 08:08
As a global leader in its industry, it's vital for a company like USANA to maintain a strong human resources department to ensure employees feel safe and taken care of. USANA would like to congratulate its vice president of HR, Mike Sessions on his...

at 08:08
Aspen Neuroscience, Inc., a California-based private biotechnology company developing personalized regenerative therapies, has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world's...

at 08:07
The American Red Cross encourages families to prepare for the fast-approaching summer swim season by learning to be "water smart." Research shows that participation in formal water safety and swim lessons can reduce the risk of drowning by 88% for...

at 08:07
KeyCare, the nation's first Epic-based virtual care company, announced today that it is collaborating with Group Health Cooperative of South Central Wisconsin (GHC-SCW) to provide 24x7 urgent care in all 50 states via virtual visits through GHC-SCW's...

at 08:05
BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic candidates for metabolic diseases, such as obesity, by targeting the biology of aging, today announced the formation of its Scientific Advisory Board (SAB)....



News published on and distributed by: